IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Portugal

  • ID: 1408493
  • Report
  • Region: Portugal
  • 46 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. Healthcare System
Facts & Figures
Market Indicators
Provision & Funding
Healthcare Cover
Healthcare Funding
Policy, Regulation and Provision

2. Pricing
Prescription Drugs
Legislative Framework
Application
Non-reimbursed Prescription Drugs
Generic Drugs
Pricing Rules
Reference Price System
Annual Price Reviews
Hospital Drugs
Pricing Rules
Purchasing
Hospital Debts
OTC Drugs

3. Reimbursement
Admission to Reimbursement
Procedure
Reimbursement Contracts
Timeline and Results
INFARMED Reviews
Reimbursement Categories
General Scheme
Special Schemes
Exceptional Use Authorisation
Reimbursement Prices
Reference Price System
Hospital Reimbursement
Assessment
Formularies
Funding
High-cost Out-patient Drugs
Changes in Reimbursement Status
INFARMED Reviews
Post-marketing Assessments
Reimbursement Categories
Changes in Reimbursement Prices
Annual Price Reviews
Price Notification System
Manufacturers’ Price Revisions
Exceptional Price Revisions
Reference Price Revisions
Post-marketing Assessments

4. Pharmacoeconomics
Pharmacoeconomic Requirements
Decree-law 97/2015
Initial Economic Assessment
Post-marketing Assessment

5. Price Build Up
Wholesalers
Margins
Discounts
Background
Retail Pharmacies
Margins
Discounts
Cheap Generic Dispensing Fee
Background
OTCs
E-pharmacy
Other Issues
Dispensing Doctors
Sales Tax

6. Cost Containment
Industry Paybacks
2016-2018 Agreement
Direct Tax on Sales
Promotional Costs
Patient Co-payments
Pharmaceuticals
Healthcare
Prescribing Controls
Physician Monitoring
INN Prescribing
Generic Substitution
E-prescribing
Prescribing Software
Hospital Prescribing
Post-marketing Assessments
Generics
Generic Substitution
INN Prescribing
Pharmacy Incentives
Rx-to-OTC Switches
Switch Process
OTC Sales
Market
Parallel Trade
Parallel Exports
Parallel Imports

7. Future Developments
Outlook
2017 Price Reviews
National Strategy for Drugs and Health Products
National Health Plan
National Patient Safety Plan 2015-20

8. Names & Addresses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll